Human Immunodeficiency Virus Type 1 Latency Model for High-Throughput Screening

Human immunodeficiency virus type 1 (HIV-1) is not eliminated from patients even after years of antiretroviral therapy, apparently due to the presence of latently infected cells. Here we describe the development of a cell-based system of latency that can be used for high-throughput screening aimed a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Micheva-Viteva, Sofiya, Pacchia, Annmarie L., Ron, Yacov, Peltz, Stuart W., Dougherty, Joseph P.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2005
Schlagworte:
Antiviral Agents
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1315948/
https://ncbi.nlm.nih.gov/pubmed/16304201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.12.5185-5188.2005
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge